DE69816337D1 - Neuroprotective verbindungen - Google Patents

Neuroprotective verbindungen

Info

Publication number
DE69816337D1
DE69816337D1 DE69816337T DE69816337T DE69816337D1 DE 69816337 D1 DE69816337 D1 DE 69816337D1 DE 69816337 T DE69816337 T DE 69816337T DE 69816337 T DE69816337 T DE 69816337T DE 69816337 D1 DE69816337 D1 DE 69816337D1
Authority
DE
Germany
Prior art keywords
sup
group
aryl
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816337T
Other languages
English (en)
Other versions
DE69816337T2 (de
Inventor
Ker Pringle
Mark Bradley
Eric Sundstrom
Fausto Iannotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Application granted granted Critical
Publication of DE69816337D1 publication Critical patent/DE69816337D1/de
Publication of DE69816337T2 publication Critical patent/DE69816337T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
DE69816337T 1997-12-16 1998-12-16 Neuroprotective verbindungen Expired - Fee Related DE69816337T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9726569.8A GB9726569D0 (en) 1997-12-16 1997-12-16 Neuroprotective agents
GB9726569 1997-12-16
PCT/GB1998/003775 WO1999031049A1 (en) 1997-12-16 1998-12-16 Neuroprotective agents

Publications (2)

Publication Number Publication Date
DE69816337D1 true DE69816337D1 (de) 2003-08-14
DE69816337T2 DE69816337T2 (de) 2004-04-15

Family

ID=10823695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816337T Expired - Fee Related DE69816337T2 (de) 1997-12-16 1998-12-16 Neuroprotective verbindungen

Country Status (20)

Country Link
US (2) US6797699B1 (de)
EP (1) EP1040096B1 (de)
JP (1) JP2002508349A (de)
KR (1) KR20010033249A (de)
CN (1) CN1284058A (de)
AT (1) ATE244698T1 (de)
AU (1) AU739296B2 (de)
CA (1) CA2315258C (de)
DE (1) DE69816337T2 (de)
DK (1) DK1040096T3 (de)
ES (1) ES2201563T3 (de)
GB (1) GB9726569D0 (de)
HK (1) HK1029331A1 (de)
HU (1) HUP0004486A3 (de)
IL (1) IL136800A (de)
NO (1) NO20003075L (de)
NZ (1) NZ505110A (de)
PT (1) PT1040096E (de)
RU (1) RU2205177C2 (de)
WO (1) WO1999031049A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
BR0307279A (pt) * 2002-01-29 2004-12-28 Wyeth Corp Métodos para fechar e abrir um semi-canal e uma célula, tecido orgãnico ou órgão, para prevenir ou tratar o estresse de tecido orgãnico ou órgão em um mamìfero, para aumentar a comunicação intracelular da junção com intervalo em uma célula, tecido orgãnico ou órgão, para tratamento de queimaduras, de tromboses, da acidose respitatória e metabólica, e da arritmia focal, para tratar e prevenir o dano de célula e tecido orgãnico resultante de nìveis elevados de glicose no sangue, para tratamento da fibrilação atrial crÈnica e da epilepsia, para criar composto candidatos que modulem a função de semi-canal, para citoproteger tecido orgãnico ou um órgão de um mamìfero em necessidade de tal tratamento, e para prevenir ou tratar o dano da reperfusão em um mamìfero
GB0202645D0 (en) * 2002-02-05 2002-03-20 Univ Southampton Treatment of chronic neurodegenerative diseases
WO2008105441A1 (ja) * 2007-02-27 2008-09-04 Ajinomoto Co., Inc. リン吸収抑制活性を有するポリアミノ酸化合物及びリン吸収抑制剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465303A (en) * 1939-04-03 1949-03-22 Research Corp Lactones
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US6262125B1 (en) * 1986-12-02 2001-07-17 University Of Florida Research Foundation, Inc. Sterically hindered tetraamines and method for their production
US5242947A (en) 1988-02-10 1993-09-07 New York University Use of polyamines as ionic-channel regulating agents
AU5957390A (en) 1989-07-03 1991-02-06 New York University Use of polyamines as ionic-channel regulating agents
FR2773798B1 (fr) 1998-01-16 2001-02-02 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US20040106560A1 (en) 2004-06-03
EP1040096A1 (de) 2000-10-04
DK1040096T3 (da) 2003-10-20
NO20003075L (no) 2000-08-15
WO1999031049A1 (en) 1999-06-24
ATE244698T1 (de) 2003-07-15
NO20003075D0 (no) 2000-06-15
RU2205177C2 (ru) 2003-05-27
PT1040096E (pt) 2003-09-30
IL136800A (en) 2005-07-25
AU1571799A (en) 1999-07-05
DE69816337T2 (de) 2004-04-15
KR20010033249A (ko) 2001-04-25
CN1284058A (zh) 2001-02-14
GB9726569D0 (en) 1998-02-11
EP1040096B1 (de) 2003-07-09
IL136800A0 (en) 2001-06-14
JP2002508349A (ja) 2002-03-19
ES2201563T3 (es) 2004-03-16
US6797699B1 (en) 2004-09-28
AU739296B2 (en) 2001-10-11
US7026297B2 (en) 2006-04-11
HUP0004486A3 (en) 2002-11-28
HUP0004486A2 (hu) 2001-05-28
HK1029331A1 (en) 2001-03-30
CA2315258A1 (en) 1999-06-24
CA2315258C (en) 2008-07-15
NZ505110A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
BR9106819A (pt) Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
GB0019359D0 (en) Novel guanidines
CA2328780A1 (en) Dihydropyrimidines
EP1679069A4 (de) Neues piperidinderivat
CA2057786A1 (en) Amino and nitro containing tricyclic compounds useful as inhibitors or ace
NO20003773L (no) Syklobutenderivater, deres fremstilling og deres terapeutiske anvendelser
ES2021182A6 (es) Procedimiento para preparar derivados de capsaicina.
DE69816337D1 (de) Neuroprotective verbindungen
ES2061319T3 (es) Utilizacion de derivados 4-(3-trifluorometifenil)-1,2,3,6-tetrahidropiridinicos como captadores de radicales libres.
DE60322565D1 (de) Antistatika und davon abgeleitete polymerzusammensetzungen
ATE102955T1 (de) Zyklisches tetrapeptid und verfahren zu dessen herstellung.
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
EP0647446A4 (de) Neue medizinische verwendung von dihydropyridinderivaten.
ATE177741T1 (de) Pharmazeutisch aktive flavilium verbindungen
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล
DE60007984D1 (de) Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
WO2001046147A8 (en) A process for preparing 4-substituted piperidines
CA2109800A1 (en) N-Hydroxyurea Derivatives Which Inhibit Lipoxygenase
TH17758EX (th) สารเคมี
TH14443EX (th) (สูตร) - อะมิโนแอลคิลและ (สูตร)-n- เพปทิดิลอะมิโนแอลคิลปอโรนิคแอซิด
TH13532EX (th) อนุพันธ์ พิริดิลอกซิซึ่งต่อต้านแผลเปื่อย การเตรียมและการใช้สารเหล่านั้น
MX9804971A (es) Derivados de tirosina como inhibidores de la alfa-v-integrina.
TH13531EX (th) สารต่อต้านเชื้อราชนิดไซคลิค เพพไทด์ และกรรมวิธีเตรียมสารเหล่านั้น

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee